Company / EPS (Diluted)
NewAmsterdam Pharma Co N.V. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.15
FY2025
5-year range
-$3.81 / -$1.19
FY2021-FY2025
Trend
-80.7%
vs FY2024
Sector context
#130 of 204
Health Care
What the data says
At $-2.15, NewAmsterdam Pharma Co N.V.'s eps (diluted) ranks #130 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 5 years, ranging from $-3.81 in FY2023 to $-1.19 in FY2024.
Based on SEC 10-K filings.
-2.15 in FY2025.
Improved from $-3.81 to $-2.15 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#130 of 204 in Health CareTop 64% of 204This company -$2.15 Sector average -$0.89
▼
-140.2% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 80.7% year-over-year.
- Ranks #130 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.15 | -80.7% |
| FY2024 | -$1.19 | +68.8% |
| FY2023 | -$3.81 | -220.2% |
| FY2022 | -$1.19 | +68.8% |
| FY2021 | -$3.81 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026